MiR-136 inhibits malignant progression of hepatocellular carcinoma cells by targeting cyclooxygenase 2.

In conclusion, miR-136 was vital in the regulation of HCC cell proliferation and metastasis by targeting COX2. Thus, our findings provided novel evidence that miR-136 might be recommended as a potential target for the diagnosis and treatment of HCC patients. PMID: 29295728 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29295728?dopt=Abstract

Source: Oncology Research - January 5, 2018 Category: Cancer & Oncology Tags: Oncol Res Source Type: research